当前位置:首页 - 行情中心 - 钱江生化(600796) - 财务分析 - 利润表

钱江生化

(600796)

  

流通市值:16.65亿  总市值:46.62亿
流通股本:3.09亿   总股本:8.67亿

利润表

报告期2024-12-312024-09-302024-06-302024-03-31
公司类型通用通用通用通用
一、营业总收入1,768,342,006.881,300,581,051.6862,661,241.69373,985,726.46
营业收入1,768,342,006.881,300,581,051.6862,661,241.69373,985,726.46
二、营业总成本1,641,541,816.941,182,695,158.87797,045,559.21357,218,304.26
营业成本1,361,719,238.23991,677,142660,882,644.34296,898,145.63
税金及附加16,496,587.410,850,343.77,434,438.362,928,132.42
销售费用16,084,800.6810,154,155.737,264,1533,233,056.03
管理费用143,703,445.6599,600,472.7968,491,646.5231,645,892.64
研发费用29,825,175.1917,701,048.316,407,747.165,008,497.68
财务费用73,712,569.7952,711,996.3536,564,929.8317,504,579.86
其中:利息费用85,764,868.4953,327,004.541,464,433.8622,753,877.88
其中:利息收入11,355,292.788,619,062.096,745,150.256,930,830.61
加:投资收益64,007,272.835,572,440.922,374,940.769,596,901.37
资产处置收益1,145,728.011,149,401.9260,962.8360,962.83
资产减值损失(新)-451,618.19-242,029.532,897,390.94-8,370.9
信用减值损失(新)-42,736,918.31-20,149,317.29-10,215,583.76-873,465.6
其他收益15,604,723.8310,063,117.326,770,746.662,877,723.35
营业利润平衡项目0000
四、营业利润164,369,378.08144,279,506.0587,504,139.9128,421,173.25
加:营业外收入10,888,985.922,160,711.551,608,266.791,531,031.9
减:营业外支出926,092.92781,268.48699,061.42150,529.62
利润总额平衡项目0000
五、利润总额174,332,271.08145,658,949.1288,413,345.2829,801,675.53
减:所得税费用48,979,399.2738,360,59522,799,148.69,109,965.49
六、净利润125,352,871.81107,298,354.1265,614,196.6820,691,710.04
持续经营净利润125,352,871.81107,298,354.1265,614,196.6820,691,710.04
归属于母公司股东的净利润160,003,849.29128,857,967.2582,251,281.4328,777,812.43
少数股东损益-34,650,977.48-21,559,613.13-16,637,084.75-8,086,102.39
(一)基本每股收益0.180.150.090.03
(二)稀释每股收益0.180.150.090.03
八、其他综合收益1,405,515.94---
归属于母公司股东的其他综合收益1,405,515.94---
九、综合收益总额126,758,387.75107,298,354.1265,614,196.6820,691,710.04
归属于母公司股东的综合收益总额161,409,365.23128,857,967.2582,251,281.4328,777,812.43
归属于少数股东的综合收益总额-34,650,977.48-21,559,613.13-16,637,084.75-8,086,102.39
公告日期2025-04-192024-10-292024-08-272024-04-26
审计意见(境内)标准无保留意见
TOP↑